Skip to main content

Table 1 Services offered in the ANC among attending women Asembo/Gem 2005 and 2002.

From: Antenatal and delivery care in rural western Kenya: the effect of training health care workers to provide "focused antenatal care"

 

Asembo 2005

Gem 2005

Asembo 2002

Gem 2002

Services

n (%)

n (%)

n (%)

n (%)

Palpation of abdomen

238/241 (98.8)

381/384 (99.2)

290/292 (99.3)

272/278 (97.8)

Listen to foetal heart rate

233/241 (96.7)

377/384 (98.2)

NA

NA

Tetanus vaccination

232/242 (95.9)

361/382 (94.5)

282/292 (96.6)

273/278 (98.2)

Weight measurement

191/241 (79.3)*

377/384 (98.2)

241/293 (82.3)*

277/278 (99.6)

Iron supplementation

197/239 (82.4)*

260/373 (69.7)

154/289 (53.3)

149/277 (53.8)

Folic acid supplementation

167/232 (72.0)*

170/356 (47.8)

153/290 (52.8)*

100/269 (37.2)

SP ≥ 1 dose

148/240 (61.7)*

74/373 (19.8)

58/286 (20.3)

63/277 (22.7)

SP ≥ 2 doses

67/237 (28.3)*

14/370 (3.8)

22/237 (9.3)

20/357 (5.6)

Blood pressure measurement

152/240 (63.3)*

274/384 (71.4)

198/292 (67.8)

187/276 (67.8)

Test haemoglobin level

72/237 (30.8)

144/377 (38.2)

148/286 (51.8)

138/274 (48.5)

Urine analysis done

73/240 (30.4)*

88/383 (23.0)

59/293 (20.1)*

30/278 (10.8)

Stool test

58/240 (24.2)*

45/384 (11.7)

50/293 (17.1)*

22/278 (7.9)

Antihelminth treatment

30/237 (12.7)*

15/365 (4.1)

13/283 (4.6)*

2/268 (0.8)

Offered test for STD (e.g. syphilis)

20/232 (8.6)

45/377 (11.9)

62/289 (21.5)

49/277 (17.7)

Offered test for HIV

26/232 (11.2)*

139/379 (36.7)

NA

NA

Health talk provided

42/240 (17.5)*

115/382 (30.1)

45/289 (15.6)

35/278 (12.6)

Information provided on:

    

   Danger signs in pregnancy

25/241 (10.4)

44/376 (11.7)

49/291 (16.8)

33/276 (12.0)

   Malaria in pregnancy

58/241 (24.0)

83/381 (21.8)

NA

NA

   Birth plan discussed

33/241 (13.7)*

80/380 (21.1)

NA

NA

   Danger signs during delivery

17/241 (7.1)

37/380 (9.7)

NA

NA

   Danger signs after delivery

11/240 (4.6)

33/381 (8.7)

NA

NA

   Breastfeeding

36/240 (15.0)*

85/383 (22.2)

NA

NA

   Family planning

18/240 (7.5)*

97/383 (25.3)

NA

NA

  1. NA: Not Available SP: sulfadoxine-pyrimethamine
  2. * p < 0.05 comparing areas in the same survey